ERAS-601, a potential best-in-class SHP2 inhibitor, blocks oncogenic signal transduction to delay onset of therapeutic resistance Combination was well-tolerated; supports…
Recovery TeamLink™ provides newfound transparency and coordination with the teams that are traveling to recover organs for transplantBALTIMORE, April 18,…
Philips 2023 FHI: Healthcare leaders focused on staff shortages Philips 2023 FHI: Healthcare leaders want to step up AI investments…
Unlocking enterprise-wide, actionable insights can help to improve outcomes April 17, 2023 Amsterdam, the Netherlands and Chicago, USA – Royal…
New domestic supply source to help address critical shortage of medical radioisotopesProprietary platform will be capable of generating up to 12 different…
Scilex Holding Company and CH Trading Group and AD Ports Group Master Distribution Agreement Signing CeremonyDesignated Territories will include the…
Preclinical data supports targeting ITK as a new approach for cancer immunotherapy Novel mechanism of action modulates T cell differentiation…
Data suggest Cyclin E1 plays a critical role in high proportion of multiple tumor types including platinum-resistant ovarian cancer Company…
Hutrukin, A Therapy Discovered and Manufactured at XBiotech, Is Aimed to Reduce Brain Injury after StrokeAUSTIN, Texas, April 17, 2023…
Preclinical data describes a novel EGFR-sparing, brain-penetrant ErbB2 inhibitor active against key oncogenic ErbB2 mutations In vivo characterization shows a…